Comparison of SCImago journal rank indicator with journal impact factor ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos The FASEB journal 22 (8), 2623-2628, 2008 | 746 | 2008 |
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections DE Karageorgopoulos, ME Falagas The Lancet infectious diseases 8 (12), 751-762, 2008 | 744 | 2008 |
Extended-spectrum β-lactamase-producing organisms ME Falagas, DE Karageorgopoulos Journal of Hospital infection 73 (4), 345-354, 2009 | 671 | 2009 |
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos The Lancet infectious diseases 10 (1), 43-50, 2010 | 662 | 2010 |
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 656 | 2011 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas Emerging infectious diseases 20 (7), 1170, 2014 | 630 | 2014 |
Etiology of anemia in patients with advanced heart failure JN Nanas, C Matsouka, D Karageorgopoulos, A Leonti, E Tsolakis, ... Journal of the American College of Cardiology 48 (12), 2485-2489, 2006 | 597 | 2006 |
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology ME Falagas, DE Karageorgopoulos Clinical infectious diseases 46 (7), 1121-1122, 2008 | 443 | 2008 |
Late Ebola virus relapse causing meningoencephalitis: a case report M Jacobs, A Rodger, DJ Bell, S Bhagani, I Cropley, A Filipe, RJ Gifford, ... The Lancet 388 (10043), 498-503, 2016 | 372 | 2016 |
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients ME Falagas, PI Rafailidis, E Ioannidou, VG Alexiou, DK Matthaiou, ... International journal of antimicrobial agents 35 (2), 194-199, 2010 | 365 | 2010 |
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis EK Vouloumanou, E Plessa, DE Karageorgopoulos, E Mantadakis, ... Intensive care medicine 37, 747-762, 2011 | 356 | 2011 |
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens DE Karageorgopoulos, R Wang, X Yu, ME Falagas Journal of Antimicrobial Chemotherapy 67 (2), 255-268, 2012 | 298 | 2012 |
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence DE Karageorgopoulos, T Kelesidis, I Kelesidis, ME Falagas Journal of Antimicrobial Chemotherapy 62 (1), 45-55, 2008 | 288 | 2008 |
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies T Kelesidis, DE Karageorgopoulos, I Kelesidis, ME Falagas Journal of antimicrobial chemotherapy 62 (5), 895-904, 2008 | 275 | 2008 |
MRSA in Africa: filling the global map of antimicrobial resistance ME Falagas, DE Karageorgopoulos, J Leptidis, IP Korbila PloS one 8 (7), e68024, 2013 | 262 | 2013 |
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies ME Falagas, AC Kastoris, DE Karageorgopoulos, PI Rafailidis International journal of antimicrobial agents 34 (2), 111-120, 2009 | 258 | 2009 |
Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis DE Karageorgopoulos, JM Qu, IP Korbila, YG Zhu, VA Vasileiou, ... Clinical Microbiology and Infection 19 (1), 39-49, 2013 | 254 | 2013 |
Short-versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis G Dimopoulos, DK Matthaiou, DE Karageorgopoulos, AP Grammatikos, ... Drugs 68, 1841-1854, 2008 | 224 | 2008 |
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin ME Falagas, S Maraki, DE Karageorgopoulos, AC Kastoris, ... International journal of antimicrobial agents 35 (3), 240-243, 2010 | 221 | 2010 |
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections N Roussos, DE Karageorgopoulos, G Samonis, ME Falagas International journal of antimicrobial agents 34 (6), 506-515, 2009 | 219 | 2009 |